What must be reported if listed chemicals are found to be adulterated or misbranded?

When listed chemicals are found to be adulterated or misbranded, it is essential to report the situation to both the Board of Pharmacy and the manufacturer. Reporting to the Board is crucial because it is responsible for regulating pharmacy practice and ensuring the safety of pharmaceutical products within the state. The Board can take actions such as investigating the issue, ensuring compliance with safety regulations, and protecting public health.

Additionally, notifying the manufacturer is vital as they need to be aware of the problem related to their product so they can address the quality issues and prevent further distribution of the adulterated or misbranded chemicals. This communication helps facilitate any necessary product recalls or corrections, maintaining the integrity of the supply chain.

In this context, simply reporting to the Board alone would not be sufficient, as it does not address the root cause with the manufacturer. Similarly, informing just the patient or any pharmacy does not encompass the responsibility to report to the regulating body and the manufacturer, which can take formal action regarding the misbranding or adulteration issues to protect public health and safety.